Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NASDAQ: SGHT

Sight Sciences, Inc.

Healthcare | Medical - Devices
$5.28
Market Cap$280M
Volume646
EPS (TTM)$-0.55

Sight Sciences, Inc. (NASDAQ: SGHT) is a $280M medical - devices company trading at $5.28. Figures from SEC EDGAR and market feeds; updated 2026-10-11 00:45 UTC.

What Sight Sciences, Inc. does

** Please share the actual "Item 1. Business" section text from a 10-K filing (or provide the ticker symbol so I can look it up). 2. **If you want financial data:** Please tell me the company's **ticker symbol** (e.g., AAPL, MSFT) and what specific information you're looking for—current stock price, historical performance, revenue, margins, etc. 3. **If you have a specific question:** Please rephrase it in plain language. The CIK number in your metadata is **0001531177**. If you'd like me to fetch data for that company, I'm happy to help once you clarify what you need.

Summarized from Sight Sciences, Inc.’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Pre-revenue, development-stage company: standard profitability ratios (P/E, EV/EBITDA, ROE) do not apply yet because there are no earnings. Watch cash, cash runway, net loss, R&D spend and share dilution instead.

Key facts

Quote
Price$5.28
Market cap$280M
Volume646 shares
Valuation
EPS (TTM)$-0.55
Price/book4.38×
Debt/equity0.77

Revenue, margins & earnings

FY2021: net loss $63M on revenue $49M$49MFY2021FY2022: net loss $86M on revenue $71M$71MFY2022FY2023: net loss $56M on revenue $81M$81MFY2023FY2024: net loss $52M on revenue $80M$80MFY2024FY2025: net loss $38M on revenue $77M$77MFY2025
  • Net income
  • Taxes & interest
  • Operating expenses
  • Cost of revenue
  • Net loss year
Annual revenue; bands show net, operating, gross margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-10-05
  • 2026-10-05Chief Financial OfficerSale-7,208$63.8K
  • 2026-10-05President and CEOSale-29,653$268.3K
  • 2026-10-05EVP, Operations & R&DSale-2,988$26.5K
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →

Questions this page answers

What does Sight Sciences, Inc. do?

Sight Sciences, Inc. is a medical - devices company, listed on NASDAQ as SGHT.

What is SGHT's valuation?

SGHT trades at $5.28, as of 2026-10-11.

When did SGHT last file with the SEC?

Sight Sciences, Inc.'s most recent SEC filing on record is a 8-K filed 2026-06-05. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings and public market data feeds, fetched 2026-10-11 00:45 UTC. This page is also available as JSON at /api/data?ticker=SGHT and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for SGHT and 5,000+ tickers.

Create a free account — keep SGHT
For your agent
GET /api/data?ticker=SGHT

This page as JSON via rel="alternate" · REST API docs · MCP server (62 tools) · llms.txt